Windlas Biotech Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 20/05/2024 ,inter alia, to consider and approve approve the audited standalone and consolidated financial results for the quarter and year ended March 31, 2024 and to consider recommendation of dividend, if any, amongst other routine matters.